SCIESCOPUSQ1
CANCER TREATMENT REVIEWS
ELSEVIER SCI LTD, United Kingdom
CANCER TREATMENT REVIEWS is an academic journal published by ELSEVIER SCI LTD (United Kingdom). Identifiers: ISSN 0305-7372, eISSN 1532-1967. Indexed in SCIE, SCOPUS. Metrics: JIF 10.5, CiteScore 17.1, SJR 4.183, SNIP 2.57. Subject areas: ONCOLOGY. tlooto lists 3,598 papers from this journal.
CiteScore
17.10
Métrica de citas de Scopus
SJR
4.183
Ranking SCImago
SNIP
2.57
Impacto normalizado por fuente
Rango percentil
-
Percentil del JIF
Perfil de la revista
- ISSN
- 0305-7372
- eISSN
- 1532-1967
- Abreviatura
- CANCER TREAT REV
- Editorial
- ELSEVIER SCI LTD
- País
- United Kingdom
categorías de Web of Science
SCIEONCOLOGY
categorías ASJC de Scopus
2730 Oncology2741 Radiology
Palabras clave
Oncology
Papers in this journal
Recent papers
- Rethinking endpoints for the watch-and-wait strategy in rectal cancer.
2026
- Erratum to "Impact of brain metastases on systemic renal cell carcinoma treatment outcomes: A systematic literature review". [Cancer Treat. Rev. 140 (2025) 103024].
2026
- Comparative efficacy and safety of novel oral selective estrogen receptor degraders in ER+/HER2- advanced breast cancer: An updated systematic review and meta-analysis of randomized controlled trials.
2026
- Diagnosis and treatment of human epidermal growth factor receptor 2-positive metastatic colorectal cancer: a systematic literature review.
2026
- Targeted precision Strike in Extensive-Stage small cell lung Cancer: Current advances and future Perspectives for Antibody-Drug conjugates.
2026 · 2 citations
Most cited papers
- PI3K/Akt signalling pathway and cancer.
2004 · 2,398 citations
- Metastatic bone disease: clinical features, pathophysiology and treatment strategies.
2001 · 1,889 citations
- Molecular mechanisms of resistance and toxicity associated with platinating agents.
2007 · 1,557 citations
- The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer.
2013 · 1,344 citations
- CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - a target for novel cancer therapy
2017 · 1,315 citations